Pfizer's vaccine for Clostridium difficile (C. US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C. diff.) infection by ...
The rate of recurrence represents perhaps one the most challenging aspect on the management of CDI. In fact, after a successful first-line treatment with standard therapies, metronidazole or ...
Symptoms range from mild to severe and can lead to complications such as dehydration, bloody stool, low blood pressure, rapid heart rate and infection in the tissues of the colon. C. diff infection is ...
CDI = Clostridium difficile infection, UTI = Urinary tract infection, n = total sample size, N = weighted average annual population estimate, CI = confidence interval ...